AzTrials
AzTrials

Difficult IntubationFRIDA-ReaNCT01532063

Risk Factors of Difficult Intubation and Related Complications in Adults in Intensive Care Units: FRIDA-Rea

A study testing INTUBATION IN INTENSIVE CARE UNIT in people with Difficult Intubation, run by University Hospital, Montpellier at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Difficult intubation is challenging in intensive care units. There are limited data regarding risk factors of difficult intubation in ICU. The primary purpose of the investigators study is to assess the risk factors of difficult airway in adults in ICU. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Difficult Intubation
What is being tested?
INTUBATION IN INTENSIVE CARE UNIT
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,400 participants
Where
1 siteFrance
Study dates
Oct 2011to Apr 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • More or equal to 18 years old
  • Men and women
  • Informed patient
  • Affiliated or benefit from an disease insurance
  • Available for a 28 days follow-up
  • Intubated patients in Intensive Care Unit

Who cannot join

  • Law protected patients
  • Opposed to participate to study

Trial locations and contacts

1 site in 1 country.

France1 site
  • University Hospital of Montpellier, Saint Eloi

    Montpellier, 34295

Other trials in France

About this study

Official title: Risk Factors of Difficult Intubation and Related Complications in Adults in Intensive Care Units(ICU)

Difficult intubation is challenging in intensive care units. There are limited data regarding risk factors of difficult intubation in ICU. The primary purpose of the investigators study is to assess the risk factors of difficult airway in adults in ICU.

Read the detailed description

PURPOSE: Intubation in ICU strongly differs from intubation in operative rooms. The results of studies about risk factors of difficult intubation performed in operative rooms cannot therefore be extrapolated directly to ICU.

The primary purpose of this trial (cf Part "Design" of this registration) is "other" and more particularly "Prognosis" because it is is an assessment of risk factors of difficult airway in intensive care units.

DESIGN AND METHODOLOGY: This is an open prospective multicentric study of intubation in ICU in more than 50 centres. Consecutive intubations will be included in each centre, in order to reach the sample size required (at least 1000 procedures intubations). The usual risk factors of difficult intubation in operative rooms, the demographic parameters and the complications of intubation will be assessed, as well as survival status at 28 days.

Being tested
INTUBATION IN INTENSIVE CARE UNIT
Keywords
Difficult intubation, Intensive care units, Risk factors, Incidence, Complications, Intubation in Intensive Care Unit, More than 2 attempts of intubation, Intubation attempts lasting more than 10 minutes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • INTUBATION IN INTENSIVE CARE UNITProcedure or surgery

    Standard intubation procedure used in Intensive Care Unit

Study groups in NCT01532063
Study groupRoleWhat they receive
INTUBATIONOtherSubjects intubed in Intensive Care Unit
Receives: Procedure: INTUBATION IN INTENSIVE CARE UNIT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difficult intubation

    According to ASA criteria, difficult intubation is measured by attempts lasting more than 10 min or more than two attempts

    Measured: until to 10 minutes

Secondary outcomes (3)
  1. Complications of intubation in ICU

    • Respiratory (inhalation, oesophageal intubation, SpO2<80%)
    • Hemodynamic(SAP<65 mm Hg, elevated or low cardiac frequency,rythm troubles, heart attack),
    • Neurologic (agitation),
    • Local (dental trauma, laryngal trauma),
    • Death
    • Complications occuring during one hour after intubation: respiratory (major desaturation: SpO2<80%, pneumothorax, persistent hypoxia with SpO2<80%), hemodynamic (persistent hypotension: SAP<90 mm Hg despite of vascular filling, rythm troubles, heart attack, introduction or majoration of amines posology), neurologic(agitation), death

    Measured: up to one hour after intubation

  2. Mortality at 28 days after difficult intubation

    Survival status at Day 28 or date of death if patient dead before.

    Measured: up to 28 days after difficult intubation

  3. Incidence of difficult intubation in ICU

    Measured: up to day 28

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Feb 2012 (estimated)
  2. Study startOct 2011
  3. Primary completionApr 2012
  4. Study completionApr 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
1,400 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01532063
Sponsor's protocol ID
8819
Other IDs
2012-A00651-42
Acronym
FRIDA-Rea
Status last verified
Sep 2025
First submitted
8 Feb 2012
Last updated
2 Oct 2025
Results posted
No
Data monitoring committee
No

Publications

  • Perbet S, De Jong A, Delmas J, Futier E, Pereira B, Jaber S, Constantin JM. Incidence of and risk factors for severe cardiovascular collapse after endotracheal intubation in the ICU: a multicenter observational study. Crit Care. 2015 Jun 18;19(1):257. doi: 10.1186/s13054-015-0975-9.

    PubMed 26084896
  • De Jong A, Molinari N, Pouzeratte Y, Verzilli D, Chanques G, Jung B, Futier E, Perrigault PF, Colson P, Capdevila X, Jaber S. Difficult intubation in obese patients: incidence, risk factors, and complications in the operating theatre and in intensive care units. Br J Anaesth. 2015 Feb;114(2):297-306. doi: 10.1093/bja/aeu373. Epub 2014 Nov 27.

    PubMed 25431308
  • De Jong A, Molinari N, Terzi N, Mongardon N, Arnal JM, Guitton C, Allaouchiche B, Paugam-Burtz C, Constantin JM, Lefrant JY, Leone M, Papazian L, Asehnoune K, Maziers N, Azoulay E, Pradel G, Jung B, Jaber S; AzuRea Network for the Frida-Rea Study Group. Early identification of patients at risk for difficult intubation in the intensive care unit: development and validation of the MACOCHA score in a multicenter cohort study. Am J Respir Crit Care Med. 2013 Apr 15;187(8):832-9. doi: 10.1164/rccm.201210-1851OC.

    PubMed 23348979

Questions about this trial

What is this clinical trial studying?

A study testing INTUBATION IN INTENSIVE CARE UNIT in people with Difficult Intubation, run by University Hospital, Montpellier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difficult intubation (time frame: until to 10 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01532063, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in